OBSV Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (22 mar 2023 @ 21:00):

ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy...

Stats
Dagens volum	8.23M
Gjennomsnittsvolum	7.95M
Markedsverdi	11.00M
EPS	$-0.190 ( Q4 \| 2022-12-01 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.138 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0240 (28.57%)

AADI -6.47%

ABCL 1.65%

ABCM 0.04%

ABEO -3.55%

ABIO -1.68%

ABOS 3.74%

ABSI 4.25%

ABUS -0.98%

ABVX -3.00%

ACAD -0.19%

ACER -17.95%

ACET -8.86%

ACGN 1.29%

ACHL -2.48%

ACHV 3.88%

ACIU -1.46%

ACLX -0.21%

ACRV -5.61%

ACST -1.68%

ACXP 3.92%

ADAG 6.07%

ADAP -2.53%

ADGI 0.87%

ADIL -1.70%

ADMA -1.86%

ADPT 0.74%

ADTX -2.78%

ADVM 1.09%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -1.57%

AGEN -3.50%

AGIO -1.99%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 5.15%

AKRO -2.53%

AKTX -2.38%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC 0.00%

ALGS 1.32%

ALKS 1.82%

ALLK -11.49%

ALLO -4.17%

ALLR -1.49%

ALNA 3.16%

ALNY 2.17%

ALPN 0.02%

ALPX 0.00%

ALRN -2.24%

ALT -13.63%

ALVR -0.69%

ALXN 0.00%

ALXO -13.55%

ALZN 4.02%

AMRN -2.51%

AMTI -3.13%

ANAB 1.17%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 2.07%

ANPC -3.15%

APGE 0.64%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 0.94%

APLT -0.56%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 0.62%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -6.51%

ARDS -12.13%

ARDX 0.83%

ARGX -0.43%

ARNA 0.00%

ARPO -0.90%

ARQT -2.86%

ARTL -2.50%

ARTLW 0.00%

ARVN 8.32%

ARWR -1.75%

ASLN -3.43%

ASMB -4.22%

ASND -1.93%

ATAI -3.33%

ATHA 6.89%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 5.34%

ATRA -3.60%

ATXI 2.70%

ATXS -1.22%

AUPH -1.08%

AURA 4.55%

AUTL -3.45%

AVBP -4.02%

AVEO 0.00%

AVIR -2.19%

AVRO -1.41%

AVTE -0.69%

AVTX -3.74%

AVXL -4.81%

AXLA 0.00%

AXSM -1.32%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.05%

BCAB -3.27%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.48%

BCRX 1.97%

BCTX 10.31%

BCTXW 13.02%

BCYC 0.85%

BDRX -4.06%

BDTX -0.64%

BEAM 2.43%

BFRA -2.91%

BGNE -2.25%

BIOR -5.27%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.46%

BLTE -1.13%

BLU 0.03%

BLUE -2.25%

BMEA -13.82%

BMRN 0.45%

BNOX 6.15%

BNTC -2.99%

BNTX -1.76%

BOLD -7.90%

BOLT -0.05%

BPMC -1.54%

BPTH -1.43%

BPTS -13.47%

BRNS -0.37%

BRTX -5.19%

BTAI 11.86%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.36%

CABA 2.28%

CADL 0.53%

CALA 0.00%

CALC -9.65%

CALT -1.59%

CAPR -0.86%

CARA -3.29%

CARM 7.42%

CASI 4.08%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.76%

CCXI 0.00%

CDAK 0.00%

CDIO -3.06%

CDIOW 24.00%

CDMO -1.27%

CDMOP 0.04%

CDT -2.44%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.58%

CDXS 9.66%

CELC -3.15%

CELU 2.67%

CELUW 11.80%

CERC -1.68%

CERE -1.26%

CERO -6.73%

CEROW -10.18%

CFRX -27.95%

CGEM 0.24%

CGEN -3.31%

CGON -1.45%

CGTX -4.35%

CHMA -6.00%

CHRS 3.79%

CINC 0.00%

CING -2.56%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -0.91%

CLGN 0.00%

CLLS -3.13%

CLNN -2.72%

CLNNW 0.00%

CLRB 7.41%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 5.61%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.38%

CNCE 0.00%

CNSP -35.21%

CNST 0.00%

CNTA 0.56%

CNTB -0.75%

CNTX -5.48%

COCP -2.00%

COEPW 32.45%

COGT -2.16%

CORT 2.60%

COYA -0.49%

CPRX -1.75%

CRBP -0.68%

CRBU -7.10%

CRDF 1.10%

CRGX -0.03%

CRIS -1.59%

CRNX -6.42%

CRSP -0.11%

CRTX 2.63%

CRVO -3.23%

CRVS 0.56%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -3.31%

CTNM 1.98%

CTXR -1.31%

CUE -3.09%

CVAC -7.49%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.53%

CYTO 0.00%

DARE 3.54%

DAWN -0.97%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 30.08%

DNLI -2.05%

DNTH -6.18%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL -0.24%

DYAI 9.68%

EARS -1.77%

EDIT -3.12%

EDSA 4.09%

EFTR 4.47%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.65%

ELEV -1.66%

ELOX 10.77%

ELTX -5.15%

ELVN -1.84%

ELYM 5.09%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA -0.65%

ENTO -4.97%

ENTX -0.53%

ENVB 4.67%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS 1.44%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -4.33%

ETON 2.90%

ETTX 0.00%

EVAX -0.71%

EVGN 5.03%

EVLO 0.00%

EWTX -0.98%

EXAI -0.38%

EXEL 0.56%

EYEG -0.69%

EYEN 0.00%

EYPT 1.45%

FATE -11.69%

FBIO 0.65%

FBIOP 0.87%

FBLG -5.60%

FBRX -0.02%

FDMT -4.93%

FENC -2.26%

FGEN -10.21%

FHTX 8.21%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.47%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.33%

FULC 1.84%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.67%

GANX -3.08%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.74%

GHRS -3.72%

GLMD -4.09%

GLPG -1.52%

GLSI 5.01%

GLTO -3.31%

GLUE -3.69%

GLYC -12.00%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.60%

GNLX -4.85%

GNPX -3.40%

GNTA 3.94%

GOSS -9.39%

GOVX -1.36%

GOVXW 10.89%

GPCR -6.41%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.69%

GRTX -1.66%

GTHX 1.59%

GUTS 2.77%

GXGXW 41.67%

GYRE -4.54%

HALO -1.56%

HARP 0.09%

HCWB -6.13%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX -1.30%

HOOK 1.99%

HOTH -0.55%

HOWL 1.92%

HRMY 3.06%

HRTX 8.36%

HSTO 0.00%

HUMA 1.52%

HUMAW -6.26%

IBRX -5.85%

ICCC -3.10%

ICPT 0.21%

ICU 15.89%

ICUCW 9.30%

ICVX -0.91%

IDRA -23.04%

IDYA -3.24%

IFRX -2.78%

IGMS -1.02%

IKNA -0.30%

IKT -9.93%

IMAB 0.58%

IMCR -3.39%

IMGN 0.02%

IMGO 0.00%

IMMP 5.13%

IMMX -6.90%

IMNM 4.26%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.25%

IMTXW 6.00%

IMUX 2.78%

IMV 0.00%

IMVT -3.26%

INAB -0.72%

INBX -2.78%

INCY -2.33%

INDP 7.34%

INFI -52.38%

INKT 2.10%

INM 0.04%

INMB 4.77%

INO 2.67%

INSM -0.86%

INTS -1.96%

INVA 0.25%

INZY 2.17%

IOBT -10.94%

IONS 1.52%

IOVA -2.72%

IPA 3.00%

IPHA 3.05%

IPSC -2.34%

IRON -2.52%

ISEE 0.38%

ITOS 1.30%

ITRM 2.33%

IVA 6.96%

IVVD 0.41%

JAGX 1.57%

JANX -4.46%

JAZZ -1.00%

JNCE 0.00%

JSPR -1.90%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.45%

KALV -3.29%

KDNY 0.22%

KMPH -0.34%

KNSA -1.90%

KNTE -0.38%

KOD -7.91%

KPRX -4.08%

KPTI -8.35%

KRBP -10.00%

KRON 1.58%

KROS -0.37%

KRRO -2.21%

KRTX 0.03%

KRYS 0.17%

KTRA 13.61%

KTTA -0.65%

KTTAW 0.92%

KURA 0.81%

KYMR -2.99%

KYTX -4.12%

KZIA 4.41%

KZR -0.15%

LABP 0.57%

LBPH -0.32%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.99%

LENZ -2.54%

LEXX -1.54%

LEXXW -14.63%

LGND -1.01%

LGNDV 0.00%

LGVN -9.61%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -3.68%

LPTX -2.75%

LQDA 0.24%

LRMR 0.21%

LSTA -1.68%

LTRN 5.85%

LUMO 1.79%

LVTX -4.12%

LXEO -8.68%

LXRX -1.76%

LYEL -35.05%

LYRA 1.98%

MACK 0.10%

MBIO -11.36%

MBRX -1.43%

MCRB 3.08%

MDGL -2.10%

MDNA -13.16%

MDWD 3.56%

MDXG -2.21%

MEIP 0.00%

MESO -1.49%

MGNX -5.13%

MGTA -7.74%

MGTX -0.95%

MGX 2.14%

MIRM 0.57%

MIRO 0.59%

MIST 2.69%

MITO 0.00%

MLEC -5.95%

MLECW 2.31%

MLND -5.36%

MLTX 0.13%

MLYS -6.08%

MNKD -0.57%

MNMD 3.54%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.42%

MORF -3.55%

MREO 0.14%

MRKR -0.43%

MRNA -9.19%

MRNS -5.51%

MRSN -2.86%

MRTX -0.17%

MRUS -0.35%

MRVI 0.07%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.03%

MYMD 1.08%

NAMS 0.34%

NAMSW -0.21%

NAUT 1.11%

NBRV 0.71%

NBSE -1.56%

NBTX 8.31%

NCNA 0.37%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.79%

NKGN 9.85%

NKGNW -18.03%

NKTR 3.74%

NKTX -3.59%

NLSP 3.53%

NLSPW 26.67%

NMRA -1.37%

NMTR -42.97%

NOVN -24.84%

NRBO 16.07%

NRIX -0.58%

NRSN -4.82%

NRSNW 0.00%

NRXP -7.81%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -5.33%

NTRBW -31.07%

NUVL -1.03%

NVAX -7.75%

NVCT -8.37%

NVIV -34.28%

NXTC -4.93%

NYMX -0.05%

OABI 2.77%

OABIW -10.06%

OBIO -1.17%

OBSV 0.00%

OCEA -2.80%

OCGN 8.55%

OCS -1.00%

OCUL 0.99%

OCUP 0.65%

ODT -4.27%

OKYO 1.72%

OLMA -4.86%

OMER -2.31%

OMGA 0.42%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -2.58%

ORGS -0.69%

ORIC -2.08%

ORMP 18.31%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.25%

OVID 0.30%

OYST 0.00%

PALI -0.22%

PASG 0.00%

PBLA -7.50%

PBM -4.69%

PBYI 2.70%

PCSA -1.93%

PCVX -0.06%

PDSB -6.38%

PEPG 1.19%

PGEN -6.29%

PHAR 2.19%

PHAS 0.00%

PHAT -0.77%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.01%

PLUR 7.39%

PMN -5.55%

PMVP -2.68%

PNT 0.16%

PPBT -6.87%

PRAX 7.63%

PRDS 0.93%

PRLD -2.64%

PROG -3.47%

PROK -0.45%

PRQR 1.17%

PRTA -2.84%

PRTC 0.62%

PRTG 4.13%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -14.04%

PSTX -2.91%

PTCT -0.77%

PTE -0.82%

PTGX -1.02%

PTIXW -48.41%

PULM 1.57%

PXMD 4.76%

PYPD 1.71%

PYXS 3.59%

QLGN -2.78%

QNCX 5.70%

QNRX 3.40%

QSI -31.96%

QSIAW -3.13%

QTTB 1.83%

QURE -0.67%

RAIN -1.63%

RANI 4.81%

RAPT -1.46%

RARE 1.81%

RCKT -9.81%

REGN -0.30%

RENB -3.73%

REPL -1.81%

RETA 0.02%

REUN -0.89%

REVB -1.86%

REVBU 3.46%

REVBW 5.00%

RGLS -6.07%

RGNX -6.57%

RIGL -6.24%

RLAY -4.67%

RLMD 0.00%

RLYB -4.70%

RNA 1.98%

RNAC -4.53%

RNAZ -0.38%

RNXT 1.79%

ROIV -1.75%

ROIVW 4.56%

RPHM -1.40%

RPRX -0.59%

RPTX -0.59%

RUBY 2.70%

RVLP -32.05%

RVMD -0.67%

RVMDW -29.90%

RVNC 0.00%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.91%

RYTM -6.15%

RYZB 0.02%

RZLT 3.62%

SABS -1.37%

SABSW -11.81%

SAGE -0.09%

SANA -2.49%

SAVA -1.81%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 10.61%

SCPS 0.00%

SEEL -6.59%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.39%

SGMT -5.80%

SGTX -2.56%

SIOX 22.63%

SLDB -2.59%

SLGL 5.23%

SLN -6.92%

SLNO 0.62%

SLRX 1.21%

SLS -2.56%

SMMT -3.37%

SNDX 3.33%

SNGX -0.38%

SNPX -0.71%

SONN -2.15%

SPPI -0.49%

SPRB -1.38%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -0.87%

SRRA 0.00%

SRRK -1.61%

SRZN -2.45%

STAB 0.00%

STOK -7.24%

STRO -3.00%

STSA 0.00%

STTK 6.89%

SURF -0.93%

SVRA -0.39%

SWTX -0.11%

SYBX 1.29%

SYRS -1.89%

TALS -0.73%

TARA -7.14%

TARS -1.98%

TBPH 0.71%

TCBP 9.84%

TCDA 0.00%

TCON 0.00%

TCRR 0.00%

TCRT -1.75%

TCRX 4.69%

TECH -0.81%

TENX -0.32%

TERN -8.28%

TFFP -7.61%

TGTX -7.19%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -6.26%

TNGX -3.24%

TNXP -7.17%

TNYA -4.03%

TPST 6.07%

TRDA -4.67%

TRVI 2.68%

TRVN 0.82%

TSHA -18.87%

TSVT -3.99%

TTNP -6.05%

TVTX 3.39%

TYRA -6.77%

UBX -2.13%

UNCY -4.00%

URGN 1.85%

UTHR -0.10%

VACC 11.36%

VALN -6.70%

VAXX 106.25%

VBIV 0.93%

VBLT -8.77%

VCEL 1.09%

VCNX 8.60%

VCYT -0.84%

VERA -5.31%

VERU 3.01%

VERV -2.49%

VIGL -1.08%

VINC 2.93%

VIR -0.98%

VIRI -5.72%

VIRX 3.98%

VKTX -1.64%

VLON -13.04%

VNDA -3.99%

VOR -6.05%

VRCA 0.21%

VRDN -3.84%

VRNA -1.73%

VRPX 1.02%

VRTX 0.14%

VSTM 4.24%

VTGN -1.25%

VTVT 0.39%

VTYX -2.72%

VXRT -1.78%

VYGR -0.64%

VYNE -5.20%

VYNT 7.78%

WINT -2.72%

WVE -9.33%

XBIO 1.03%

XBIT 6.65%

XCUR 3.77%

XENE -1.74%

XERS 4.76%

XFOR 4.15%

XLO 4.42%

XLRN 0.00%

XNCR 0.47%

XOMA -9.20%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.55%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.46%

ZNTL -1.79%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-04-06	Loumaye Ernest	Buy	4 000 000	Common Shares
2023-02-28	Loumaye Ernest	Buy	4 000 000	Common Shares
2023-02-23	Brown William Michael	Buy	250 000	Employee Stock Option (right to buy)
2023-01-01	Loumaye Ernest	Sell	0	Common Stock
2023-01-01	Mathers Edward T	Sell	32 000	Stock Option (right to buy)

INSIDER POWER
78.24
Last 14 transactions
Buy: 8 250 000 \| Sell: 1 374 140

Volum Korrelasjon

Lang: 0.13 (neutral)

Kort: 0.22 (neutral)

Signal:(39.484) Neutral

Obseva SA Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Obseva SA Korrelasjon - Valuta/Råvare

-0.32
( neutral )

0.50
( neutral )

0.00
( neutral )

-0.49
( neutral )

0.00
( neutral )

0.70
( moderate )

Obseva SA Økonomi

Annual	2022
Omsetning:	$19.64M
Bruttogevinst:	$19.64M (100.00 %)
EPS:	$-0.320

FY	2022
Omsetning:	$19.64M
Bruttogevinst:	$19.64M (100.00 %)
EPS:	$-0.320

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.337

FY	2020
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.670

Financial Reports:

No articles found.

Obseva SA Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Obseva SA

ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. The company is also involved in developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, which is in Phase II clinical trial as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist that is in Phase I clinical trial to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.